BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 27480179)

  • 21. IL-6R/STAT3/miR-204 feedback loop contributes to cisplatin resistance of epithelial ovarian cancer cells.
    Zhu X; Shen H; Yin X; Long L; Chen X; Feng F; Liu Y; Zhao P; Xu Y; Li M; Xu W; Li Y
    Oncotarget; 2017 Jun; 8(24):39154-39166. PubMed ID: 28388577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simultaneous suppression of Src and signal transducer and activator of transcription 3 inhibits the growth of epithelial ovarian cancer cells.
    Lee SW; Yoo J; Lee SH; Kim D; Kim YM; Kim YT
    Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(1):75-9. PubMed ID: 23427943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Corilagin sensitizes epithelial ovarian cancer to chemotherapy by inhibiting Snail‑glycolysis pathways.
    Jia L; Zhou J; Zhao H; Jin H; Lv M; Zhao N; Zheng Z; Lu Y; Ming Y; Yu Y
    Oncol Rep; 2017 Oct; 38(4):2464-2470. PubMed ID: 28791374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 17β-Estradiol Reverses Leptin-Inducing Ovarian Cancer Cell Migration by the PI3K/Akt Signaling Pathway.
    Hoffmann M; Fiedor E; Ptak A
    Reprod Sci; 2016 Nov; 23(11):1600-1608. PubMed ID: 27255147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early responses of the STAT3 pathway to platinum drugs are associated with cisplatin resistance in epithelial ovarian cancer.
    Sheng WJ; Jiang H; Wu DL; Zheng JH
    Braz J Med Biol Res; 2013 Aug; 46(8):650-8. PubMed ID: 23969971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of apoptosis by metformin in epithelial ovarian cancer: involvement of the Bcl-2 family proteins.
    Yasmeen A; Beauchamp MC; Piura E; Segal E; Pollak M; Gotlieb WH
    Gynecol Oncol; 2011 Jun; 121(3):492-8. PubMed ID: 21388661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Asiatic acid exerts anticancer potential in human ovarian cancer cells via suppression of PI3K/Akt/mTOR signalling.
    Ren L; Cao QX; Zhai FR; Yang SQ; Zhang HX
    Pharm Biol; 2016 Nov; 54(11):2377-2382. PubMed ID: 26984021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A3 adenosine receptor agonist induce G1 cell cycle arrest via Cyclin D and cyclin-dependent kinase 4 pathways in OVCAR-3 and Caov-4 cell lines.
    Joshaghani HR; Jafari SM; Aghaei M; Panjehpour M; Abedi H
    J Cancer Res Ther; 2017; 13(1):107-112. PubMed ID: 28508842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RhoA/ROCK pathway mediates leptin-induced uPA expression to promote cell invasion in ovarian cancer cells.
    Ghasemi A; Hashemy SI; Aghaei M; Panjehpour M
    Cell Signal; 2017 Apr; 32():104-114. PubMed ID: 28104444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cooperation of bisphenol A and leptin in inhibition of caspase-3 expression and activity in OVCAR-3 ovarian cancer cells.
    Ptak A; Rak-Mardyła A; Gregoraszczuk EL
    Toxicol In Vitro; 2013 Sep; 27(6):1937-43. PubMed ID: 23850738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of Cepharanthine Cytotoxicity in Human Ovarian Cancer Cells.
    Payon V; Kongsaden C; Ketchart W; Mutirangura A; Wonganan P
    Planta Med; 2019 Jan; 85(1):41-47. PubMed ID: 30142661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Syringic acid regulates suppression of the STAT3/JNK/AKT pathway via inhibition of human ovarian teratoma cancer cell (PA-1) growth-in vitro study.
    Yang L; Qu C; Jin J; Yang H; Pei L
    J Biochem Mol Toxicol; 2021 Jun; 35(6):1-9. PubMed ID: 33759321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malignant ascites enhances migratory and invasive properties of ovarian cancer cells with membrane bound IL-6R in vitro.
    Kim S; Gwak H; Kim HS; Kim B; Dhanasekaran DN; Song YS
    Oncotarget; 2016 Dec; 7(50):83148-83159. PubMed ID: 27825119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. (E)-2-methoxy-4-(3-(4-methoxyphenyl)prop-1-en-1-yl)phenol suppresses ovarian cancer cell growth via inhibition of ERK and STAT3.
    Zheng J; Son DJ; Lee HL; Lee HP; Kim TH; Joo JH; Ham YW; Kim WJ; Jung JK; Han SB; Hong JT
    Mol Carcinog; 2017 Sep; 56(9):2003-2013. PubMed ID: 28277616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Granulocyte colony-stimulating factor receptor signalling via Janus kinase 2/signal transducer and activator of transcription 3 in ovarian cancer.
    Kumar J; Fraser FW; Riley C; Ahmed N; McCulloch DR; Ward AC
    Br J Cancer; 2014 Jan; 110(1):133-45. PubMed ID: 24220695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Goserelin promotes the apoptosis of epithelial ovarian cancer cells by upregulating forkhead box O1 through the PI3K/AKT signaling pathway.
    Zhang N; Qiu J; Zheng T; Zhang X; Hua K; Zhang Y
    Oncol Rep; 2018 Mar; 39(3):1034-1042. PubMed ID: 29286125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leptin stimulation of cell cycle and inhibition of apoptosis gene and protein expression in OVCAR-3 ovarian cancer cells.
    Ptak A; Kolaczkowska E; Gregoraszczuk EL
    Endocrine; 2013 Apr; 43(2):394-403. PubMed ID: 22968658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel superactive leptin antagonists and their potential therapeutic applications.
    Gertler A; Elinav E
    Curr Pharm Des; 2014; 20(4):659-65. PubMed ID: 23688008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miRNA-150 downregulation promotes pertuzumab resistance in ovarian cancer cells via AKT activation.
    Wuerkenbieke D; Wang J; Li Y; Ma C
    Arch Gynecol Obstet; 2015 Nov; 292(5):1109-16. PubMed ID: 25986891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abortifacient metapristone (RU486 derivative) interrupts CXCL12/CXCR4 axis for ovarian metastatic chemoprevention.
    Zheng N; Chen J; Li T; Liu W; Liu J; Chen H; Wang J; Jia L
    Mol Carcinog; 2017 Aug; 56(8):1896-1908. PubMed ID: 28277622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.